Cleared Traditional

K193632 - LassoStar Circular Mapping Catheter

K193632 is an FDA 510(k) clearance for LassoStar Circular Mapping Catheter, manufactured by Biosense Webster, Inc.. The device is a Class 2 Cardiovascular device with product code DRF cleared through the Traditional 510(k) pathway after a 186-day FDA review.

K193632 · Biosense Webster, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2020
Decision
186d
Days
Class 2
Risk

K193632 is an FDA 510(k) clearance for the LassoStar Circular Mapping Catheter. Classified as Catheter, Electrode Recording, Or Probe, Electrode Recording (product code DRF), Class II - Special Controls.

Submitted by Biosense Webster, Inc. (Irvin, US). The FDA issued a Cleared decision on June 30, 2020 after a review of 186 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1220 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Biosense Webster, Inc. devices

FDA 510(k) Submission Details - K193632

510(k) Number K193632 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 27, 2019
Decision Date June 30, 2020
Days to Decision 186 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d slower than avg
Panel avg: 125d · This submission: 186d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRF Device Classification - Class 2, Special Controls

Product Code DRF Catheter, Electrode Recording, Or Probe, Electrode Recording
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

All 140
Devices cleared under the same product code (DRF) and FDA review panel - the closest regulatory comparables to K193632.
Blazer™ Dx-20 Bidirectional Steerable Diagnostic Catheter
K211375 · Boston Scientific Corporation · Sep 2021
MultiCath, AcQRate Dx Fixed Curve Catheter
K201445 · Biotronik, Inc. · Sep 2021
Reprocessed Inquiry Steerable Diagnostic EP Catheter
K203261 · Innovative Health, LLC · Mar 2021
Reprocessed Achieve Advance Mapping Diagnostic Electrophysiology Catheter
K191880 · Innovative Health, LLC · Dec 2019
IntellaMap Orion High Resolution Mapping Catheter
K192360 · Boston Scientific Corporation · Oct 2019
Advisor VL Circular Mapping Catheter, Sensor Enabled
K192037 · Abbott Medical · Sep 2019